Versant Capital Management, Inc - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 232 filers reported holding SEATTLE GENETICS INC in Q4 2015. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$2,000
+100.0%
110.0%0.00%
Q2 2020$1,0000.0%110.0%0.00%
-100.0%
Q1 2020$1,0000.0%110.0%0.00%0.0%
Q4 2019$1,0000.0%11
-50.0%
0.00%
Q3 2019$1,0000.0%220.0%0.00%
Q2 2019$1,000
-50.0%
22
-12.0%
0.00%
Q1 2019$2,000
+100.0%
25
+4.2%
0.00%
Q4 2018$1,0000.0%240.0%0.00%
Q3 2018$1,0000.0%240.0%0.00%
Q2 2018$1,0000.0%24
-7.7%
0.00%
Q1 2018$1,0000.0%26
-16.1%
0.00%
Q4 2017$1,0000.0%310.0%0.00%
-100.0%
Q3 2017$1,000
-50.0%
31
-24.4%
0.00%0.0%
Q2 2017$2,0000.0%410.0%0.00%0.0%
Q1 2017$2,0000.0%41
-25.5%
0.00%0.0%
Q4 2016$2,000
-60.0%
55
-41.5%
0.00%
-66.7%
Q3 2016$5,000
+66.7%
940.0%0.00%
+50.0%
Q2 2016$3,0000.0%94
-3.1%
0.00%0.0%
Q1 2016$3,000
-40.0%
97
-14.9%
0.00%
-33.3%
Q4 2015$5,0001140.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Baker Brothers Advisors 51,049,760$3,738,884,00023.93%
Lagoda Investment Management, L.P. 76,873$5,630,0007.16%
Matrix Capital Management Company, LP 3,141,852$230,109,0006.14%
DOMINI IMPACT INVESTMENTS LLC 3,120$229,0003.51%
Opus Point Partners Management, LLC 17,832$1,306,0001.77%
Capital International Sarl 188,200$13,784,0001.72%
EMORY UNIVERSITY 33,368$2,444,0001.72%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 60,900$4,460,0001.65%
CAPITAL GUARDIAN TRUST CO 1,358,254$99,415,0001.32%
Rhenman & Partners Asset Management AB 150,598$11,030,0001.29%
View complete list of SEATTLE GENETICS INC shareholders